Well - this makes alot of sense.
In after-hours trading Acadia is now up to $31.7 a share. That's an increase in market cap of US$0.96b = AU$1.4 billion.
Meanwhile, lame duck Neuren has risen just $1,59 a share - can't even reach the $15 it was just weeks ago. This $1.59 a share is a market cap increase of AU$200 million - less than one seventh Acadias increase!
Neuren is easily worth AU$2 billion just on Acadia deal for Trof North America. So the market currently values Neuren's other opportunities plus this deal (including US$100 million up front cash) at -AU$300 million.
The sooner Acadia do a share swap with Neuren and we get US listed shares (instead of the wet blanket ASX) the better!
Am underwhelmed...
- Forums
- ASX - By Stock
- NEU
- Ann: Neuren and Acadia expand global partnership for trofinetide
NEU
neuren pharmaceuticals limited
Add to My Watchlist
6.69%
!
$14.20

Ann: Neuren and Acadia expand global partnership for trofinetide, page-40
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$14.20 |
Change
0.890(6.69%) |
Mkt cap ! $1.761B |
Open | High | Low | Value | Volume |
$13.50 | $14.26 | $12.96 | $9.111M | 655.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 2000 | $14.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$14.23 | 3278 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1300 | 14.030 |
1 | 500 | 14.000 |
1 | 357 | 13.970 |
1 | 30 | 13.900 |
1 | 700 | 13.700 |
Price($) | Vol. | No. |
---|---|---|
14.260 | 2920 | 1 |
14.300 | 1000 | 1 |
14.380 | 72 | 1 |
14.400 | 1000 | 1 |
14.460 | 434 | 1 |
Last trade - 16.15pm 27/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online